TP53 and neoplasm: Recent research has increasingly focused on elucidating the complex mechanisms underlying pancreatic tumorigenesis, encompassing key genetic alterations (e.g., KRAS, TP53 mutations), the dynamic role of the tumor microenvironment (TME), and the strategies employed by tumors to evade immune surveillance [3, 4, 5].